Literature DB >> 1313627

Vaccinia-rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea.

M E Andrew1, D B Boyle, B E Coupar, D Reddy, A R Bellamy, G W Both.   

Abstract

Recombinant vaccinia viruses expressing wild type intracellular VP7 (VP7wt) from rotavirus SA11 or VP7sc, a cell surface-anchored variant, boosted antibody titres in SA11-immune mice. Pups born to these mice were protected from diarrhoea following challenge with SA11. In rotavirus-naive mice, two immunizations with recombinant vaccinia virus expressing VP7sc stimulated protective immunity that could be transferred to pups, whereas viruses expressing VP7wt did not stimulate protective immunity. Recombinant vaccinia viruses expressing intracellular or cell surface-anchored VP6, the rotavirus group-reactive antigen from the inner capsid, did not stimulate protective immunity. These experiments demonstrate that a live viral vector expressing cell surface anchored VP7 may represent a strategy for the development of safe, effective vaccines against rotavirus-induced diarrhoea.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313627     DOI: 10.1016/0264-410x(92)90010-h

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Rotavirus virus-like particles administered mucosally induce protective immunity.

Authors:  C M O'Neal; S E Crawford; M K Estes; M E Conner
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Attenuated poliovirus strain as a live vector: expression of regions of rotavirus outer capsid protein VP7 by using recombinant Sabin 3 viruses.

Authors:  N M Mattion; P A Reilly; S J DiMichele; J C Crowley; C Weeks-Levy
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

3.  Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles.

Authors:  S E Crawford; M K Estes; M Ciarlet; C Barone; C M O'Neal; J Cohen; M E Conner
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea.

Authors:  A Coste; J C Sirard; K Johansen; J Cohen; J P Kraehenbuhl
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 5.  Rotavirus vaccines: an overview.

Authors:  K Midthun; A Z Kapikian
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

6.  Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein.

Authors:  A H Choi; M Basu; M M McNeal; J D Clements; R L Ward
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs.

Authors:  L Yuan; A Geyer; D C Hodgins; Z Fan; Y Qian; K O Chang; S E Crawford; V Parreño; L A Ward; M K Estes; M E Conner; L J Saif
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Oral immunization with rotavirus VP7-CTB fusion expressed in transgenic Arabidopsis thaliana induces antigen-specific IgA and IgG and passive protection in mice.

Authors:  Yuxian Li; Lili Guan; Xiuming Liu; Weican Liu; Jing Yang; Xiaomei Zhang; Fawei Wang; Yongxin Guo; Haiyan Li; Xiaokun Li
Journal:  Exp Ther Med       Date:  2018-03-28       Impact factor: 2.447

Review 9.  Rotaviruses: immunological determinants of protection against infection and disease.

Authors:  P A Offit
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

10.  Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity.

Authors:  M Ciarlet; S E Crawford; C Barone; A Bertolotti-Ciarlet; R F Ramig; M K Estes; M E Conner
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.